Oscar Health, Inc. (NYSE: OSCR)

Sector: Healthcare Industry: Healthcare Plans CIK: 0001568651
Market Cap 3.51 Bn
P/B 3.59
P/E -7.92
P/S 0.30
ROIC (Qtr) -25.40
Div Yield % 0.00
Rev 1y % (Qtr) 17.25
Total Debt (Qtr) 430.10 Mn
Debt/Equity (Qtr) 0.44
Add ratio to table...

About

Oscar Health, Inc., or simply Oscar, is a health insurance company based in the United States. Since its inception in 2012, the company has been dedicated to making healthcare accessible and affordable for all. Oscar has gained recognition for its innovative approach to healthcare, which includes a full-stack technology platform and a strong focus on member experience. The company's primary source of revenue comes from direct and assumed policy premiums, with the majority coming from individual and small group markets. Oscar offers a range of health...

Read more

Investment thesis

Bull case

  • Strong operating cash flow of 1.09B provides robust 2.55x coverage of total debt 430.10M, indicating excellent debt servicing capability and financial flexibility.
  • Operating cash flow of 1.09B provides exceptional 4414.73x coverage of minority interest expenses 248000, showing strong core operations.
  • Strong tangible asset base of 6.33B provides 14.71x coverage of total debt 430.10M, indicating robust asset backing and low credit risk.
  • Operating cash flow of 1.09B provides exceptional 62.20x coverage of interest expenses 17.60M, showing strong debt service capability.
  • Operating cash flow of 1.09B provides strong 12.49x coverage of stock compensation 87.65M, indicating sustainable incentive practices.

Bear case

  • Operating cash flow of 1.09B barely covers its investment activities of (241.06M), with a coverage ratio of -4.54, indicating heavy reliance on external financing for growth which may not be sustainable in a tighter credit environment.
  • Operating earnings of (419.94M) show weak coverage of depreciation charges of 28.89M, with a -14.53 ratio indicating high capital intensity and potential reinvestment needs.
  • Long-term investments of 1.50B represent a high 17.02x of fixed assets 88.35M, indicating potential overexposure to financial assets versus operational capabilities.
  • Retained earnings of (3.29B) provide limited buffer against comprehensive income items of 18.03M, which is -182.72x, indicating elevated exposure to market risks.
  • Tangible assets of 6.33B provide limited backing for working capital of (249.18M), which is -25.38x, suggesting increased operational risk in market downturns.

Peer comparison

Companies in the Healthcare Plans
S.No. Ticker Company Market Cap P/E P/S Total Debt (Qtr)
1 UNH Unitedhealth Group Inc 275.49 Bn 47.39 1.75 80.14 Bn
2 CVS CVS HEALTH Corp 101.72 Bn 15.33 0.40 79.95 Bn
3 CI Cigna Group 85.42 Bn 23.60 0.41 34.04 Bn
4 ELV Elevance Health, Inc. 77.22 Bn 13.64 0.39 32.05 Bn
5 HUM Humana Inc 25.29 Bn 14.38 0.43 12.92 Bn
6 CNC Centene Corp 20.34 Bn -3.05 0.10 17.40 Bn
7 MOH Molina Healthcare, Inc. 7.17 Bn 15.19 0.16 3.95 Bn
8 ALHC Alignment Healthcare, Inc. 3.90 Bn -187.18 1.07 0.33 Bn

Industry comparisons

Current Valuation Value Ind Avg Percentile
EV to Assets EV to Assets 0.32 1.08
EV to Cash from Ops. EV/CFO 1.87 3.83
EV to Debt EV to Debt 4.76 9.18
EV to EBIT EV/EBIT -4.88 -1,594.13
EV to EBITDA EV/EBITDA -5.57 15.88
EV to Free Cash Flow [EV/FCF] EV/FCF 1.94 8.41
EV to Market Cap EV to Market Cap 0.58 1.08
EV to Revenue EV/Rev 0.18 0.68
Price to Book Value [P/B] P/B 3.59 4.79
Price to Earnings [P/E] P/E -7.92 -5.08
Dividend Metrics Value Ind Avg Percentile
Dividend Coverage Ratio Dividend Coverage Ratio 0.00 1.21
Dividend Payout Ratio % Div Payout % (Qtr) 0.00 29.17
Dividend per Basic Share Div per Share (Qtr) 0.00 2.51
FCF Dividend Payout Ratio % FCF Div Payout % (Qtr) 0.00 16.79
Interest Coverage Int. cover (Qtr) -23.86 -0.47
Growth Metrics Value Ind Avg Percentile
Capex Growth (1y) % Capex 1y % (Qtr) -30.38 -30.05
Cash and Equivalents Growth (1y) % Cash & Equiv 1y % (Qtr) 81.65 18.06
Dividend Growth (1y) % Dividend Growth (1y) % 0.00 2.04
EBIAT Growth (1y) % EBIAT 1y % (Qtr) -1,069.51 -108.29
EBITDA Growth (1y) % EBITDA 1y % (Qtr) -510.99 -60.87
EBIT Growth (1y) % EBIT 1y % (Qtr) -843.65 -84.20
EBT Growth (1y) % EBT 1y % (Qtr) -1,436.55 -142.02
EPS Growth (1y) % EPS 1y % (Qtr) -1,636.36 -164.11
FCF Growth (1y) % FCF 1y % (Qtr) 11.38 111.09
Gross Profit Growth (1y) % Gross Profit 1y % (Qtr) -8.81 7.06
Liquidity Ratios Value Ind Avg Percentile
Asset Utilization Ratio Asset Util Ratio (Qtr) 1.85 2.20
Cash Payout Ratio Cash Payout (Qtr) 0.00 0.11
Cash Ratio Cash Ratio (Qtr) 0.57 0.48
Current Ratio Curr Ratio (Qtr) 0.95 1.46
Debt to Equity Ratio Debt/Equity (Qtr) 0.44 0.77
Interest Cover Ratio Int Coverage (Qtr) -23.86 -0.47
Times Interest Earned Times Interest Earned (Qtr) -23.86 -0.47
Profitability Value Ind Avg Percentile
EBITDA Margin % EBITDA Margin % (Qtr) -3.30 1.97
EBIT Margin % EBIT Margin % (Qtr) -3.59 1.42
EBT Margin % EBT Margin % (Qtr) -3.74 0.98
Gross Margin % Gross Margin % (Qtr) 14.40 14.54
Net Profit Margin % Net Margin % (Qtr) -3.80 0.45